Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125. - Wikidata - wikimedia - TriplyDB

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

http://www.wikidata.org/entity/Q37406838

about

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

P2860

Q47229133-BC2FFAAB-45BB-4D38-B674-F2A69C27FFEB Q55280402-961039E3-32E5-42AE-BB3F-DB86CF9DB774

P2860

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

http://www.wikidata.org/entity/Q37406838

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diagnostic usefulness of the R ...... article immunoassay for CA125.

@en

Diagnostic usefulness of the R ...... article immunoassay for CA125.

@nl

type

label

Diagnostic usefulness of the R ...... article immunoassay for CA125.

@en

Diagnostic usefulness of the R ...... article immunoassay for CA125.

@nl

prefLabel

Diagnostic usefulness of the R ...... article immunoassay for CA125.

@en

Diagnostic usefulness of the R ...... article immunoassay for CA125.

@nl

P1433

Q37406838-8E562002-B959-4E68-8EC4-C2B8CBA3AE58

P1476

Q37406838-E34F5538-53A9-45A2-BC03-35876348198D

P2093

Q37406838-BDD71EF3-913F-4E15-80EE-065673023847

Q37406838-EB5F9208-DA42-4415-9183-940B41C44DD9

P2860

Q37406838-02BEA89E-7F92-49C3-9A16-86198BF4E993

Q37406838-26690B74-3F66-4B01-8425-FC0BC7D000D6

Q37406838-34D3851A-1F55-4754-AA3D-4F11F414B141

Q37406838-3F5E610B-D93E-4457-8F0D-CCCB643678A5

Q37406838-42948381-EC18-447A-A496-EF4F5A56B178

Q37406838-50C2D35F-4D90-4C8F-8F3C-3D593E9075D3

Q37406838-59563F30-16BC-4A08-83A3-F5548129862A

Q37406838-5C2E1E55-3390-4CBB-BB0E-D8D958BEEE0B

Q37406838-5EE9A21F-ACF0-4485-9F78-4F26DEF4B0BF

Q37406838-62BB84BE-69D3-44B3-BF0B-47EB4AEAC014

P304

Q37406838-8A36263E-4FCE-46C7-ABED-14273B34B1E0

P31

Q37406838-8FF93312-DAF7-4240-808E-7DD7BBD6BBCE

P356

Q37406838-A54F4841-6DC7-418F-8EB8-3DB3D82C9114

P433

Q37406838-D0F232D2-E4C3-4D7A-9845-2C916992EF76

P478

Q37406838-E62DB2DF-B958-4273-B31A-9E60F8B87B0C

P50

Q37406838-775BFA89-DDF2-44AC-8067-8739EBF16EB0

Q37406838-7D1B7870-FC62-40A6-85AD-F812E68BD63A

P577

Q37406838-3663EAB7-31B8-47A8-AC01-A049D815B4D2

P698

Q37406838-FF3400BC-E408-4ABF-8ECD-29CA1B1C7501

P921

Q37406838-10085558-24e7-430d-8121-45c21f074bcb

P932

Q37406838-5260D9C0-3B82-45E7-9E0E-84EEC0F746FD

P356

P1433

Oncology Letters

P1476

Diagnostic usefulness of the R ...... particle immunoassay for CA125

@en

P2093

Aneta Cymbaluk-Płoska

http://www.w3.org/2001/XMLSchema#string

Katarzyna Luterek-Puszyńska

http://www.w3.org/2001/XMLSchema#string

P2860

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.

Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.

Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.

Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4 assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study.

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.

Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.

P304

3101-3114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5058

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

A Chudecka-Głaz

Janusz Menkiszak

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27899969

http://www.w3.org/2001/XMLSchema#string

P921

P932

5103905

http://www.w3.org/2001/XMLSchema#string